• Profile
Close

Effects of vildagliptin add-on insulin therapy on nocturnal glycemic variations in uncontrolled type 2 diabetes

Diabetes Therapy Sep 21, 2017

Li FF, et al. - This study was coordinated to examine whether vildagliptin add-on insulin therapy improved glycemic variations in patients with uncontrolled type 2 diabetes (T2D) compared to patients with placebo therapy. In patients with uncontrolled T2D, vildagliptin add-on therapy to insulin had the ability to improve glycemic variations, particularly during the nocturnal time period.

Methods
  • The authors performanced a 24-week, single-center, double-blind, placebo-controlled trial.
  • Between June 2012 and April 2013, they recruited inadequately controlled T2D patients treated with insulin therapy.
  • The trial included a 2-week screening period and a 24-week randomized period.
  • They randomly assigned subjects to a vildagliptin add-on insulin therapy group (n = 17) or a matched placebo group (n = 16).
  • At weeks 4, 8, 12, 16, 20, and 24, scheduled visits occurred.
  • They performed continuous glucose monitoring (CGM) before and at the endpoint of the study.

Results
  • In this study, 33 subjects were admitted, with 1 patient withdrawing from the placebo group.
  • HbA1c values were significantly reduced at the endpoint in the vildagliptin add-on group after 24 weeks of therapy.
  • CGM data demonstrated that patients with vildagliptin add-on therapy had a significantly lower 24-h mean glucose concentration and mean amplitude of glycemic excursion (MAGE).
  • Compared to the control patients, patients in the vildagliptin add-on group had a significantly lower MAGE and standard deviation during the nocturnal period (0000-0600) at the endpoint of the study.
  • In either group, a severe hypoglycemic episode was not observed.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay